Author :   Kryachok I.

Experience of the treatment of NK-/T-cell lymphomas with SMILE regimens. Clinical case
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. Т. 11, № 1-2 (41-42)
Multiple myeloma associated secondary systemic AL-amyloidosis: a case report and a literature review
Authors: Rudiuk T. Novosad O. Shevchuk L. Kundina V.... Т. 11, № 1-2 (41-42)
Primary-multiple tumors. Synchronous non-Hodgkin’s lymphoma from mantle zone cells and gastric adenocarcinoma. Clinical case
Authors: Kryachok I. Shudrak N.А. Stepanishyna Y.A. Antonyuk S.A.... T. 10, № 3-4 (39-40)
Modern approaches to the treatment of the extranodal NK/T-cell lymphoma
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. T. 10, № 1-2 (37-38)
Hair cell leukemia: a literature review and a clinical case
Authors: Kryachok I. Titorenko I.B. Т. 9, № 3 (35) 2019
Changing the Treatment Landscape of multiple myeloma (2003–2013). Own results
Authors: Novosad O. Kryachok I. Ulianchenko K.O. Skripets Т.V.... Т. 9, № 2 (34) 2019
AL-amyloidosis: challenges and perspectives
Authors: Kryachok I. Stepanishyna Y.A. Т. 9, № 1 (33) 2019
The role of PET in patients with relapsе and refractory of Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. Т. 8, № 4 (32) 2018
Immunotherapy of Hodgkin’s lymphoma: a new treatment strategy
Author:Kryachok I. Т. 8, № 2 (30) 2018
Quality of life level in patients with diffuse large B-cell lymphoma from high-risk group treated with R-DA-EPOCH regimen
Authors: Filonenko K.S. Kryachok I. Stepanishyna Y.A. Martynchyk A.V.... №4(28) 2017
Immunohistochemical c-MYC expression in different subtypes of diffuse large B-cell lymphoma
Authors: Kryachok I. Martynchyk A.V. Filonenko K.S. Stepanishyna Y.A.... №4(28) 2017
The prognostic value of functional parameters of PET-CT in the primary mediastinal large B-cell lymphoma
Authors: Kryachok I. Stepanishyna Y.A. Kmetyuk Y.V. Guryanov V.G. №3(27) 2017